Cargando…
Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies
Despite decades of research and successful improvements in diagnosis and therapy, prostate cancer (PC) remains a major challenge. In recent years, it has become clear that PC stem cells (PCSCs) are the driving force in tumorigenesis, relapse, metastasis, and therapeutic resistance of PC. In this min...
Autores principales: | Wolf, Isis, Gratzke, Christian, Wolf, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304860/ https://www.ncbi.nlm.nih.gov/pubmed/35875084 http://dx.doi.org/10.3389/fonc.2022.935715 |
Ejemplares similares
-
Synergistic Cytotoxicity of a Toxin Targeting the Epidermal Growth Factor Receptor and the Glycosylated Triterpenoid SO1861 in Prostate Cancer
por: Fischer, Alexandra, et al.
Publicado: (2023) -
Targeting Prostate Cancer Stem Cells with Alpha-Particle Therapy
por: Ceder, Jens, et al.
Publicado: (2017) -
Tumor-Specific Induction of the Intrinsic Apoptotic Pathway—A New Therapeutic Option for Advanced Prostate Cancer?
por: Wolf, Philipp
Publicado: (2019) -
Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer
por: Wolf, Philipp
Publicado: (2023) -
Enhanced cytotoxicity of a Pseudomonas Exotoxin A based immunotoxin against prostate cancer by addition of the endosomal escape enhancer SO1861
por: Masilamani, Anie P., et al.
Publicado: (2023)